KDR and hepatocellular carcinoma: Another study has revealed that DNA demethylation and histone modification at the promoter region enhances the overexpression of protein thymosin β4 (Tβ4), which contributes to drug resistance in hepatocellular carcinoma (HCC) cell line to VEGFR inhibitor sorafenib [76].